Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations

The presence of minimal residual disease (MRD) is widely recognized as a powerful predictor of therapeutic outcome in acute myeloid leukemia (AML), but methods of measurement and quantification of MRD in AML are not yet standardized in clinical practice. There is an urgent, unmet need for robust and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Mol Diagn
Main Authors: Mencia-Trinchant, Nuria, Hu, Yang, Alas, Maria Antonina, Ali, Fatima, Wouters, Bas J., Lee, Sangmin, Ritchie, Ellen K., Desai, Pinkal, Guzman, Monica L., Roboz, Gail J., Hassane, Duane C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Investigative Pathology 2017
Assuntos:
Regular Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5500824/
https://ncbi.nlm.nih.gov/pubmed/28525762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2017.03.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados